newsfilter
← Latest News
GlobeNewswire·

Monopar Therapeutics Announces 1-for-5 Reverse Stock Split

WILMETTE, Ill., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced that it